[Significance of CA72-4 as a follow up of recurrent gastric cancer--comparison with CEA and CA19-9].
We studied a significance of serum CA72-4 as a follow up of recurrent gastric cancer in 24 recurrent cases with gastric cancer performed combination assay of CEA, CA19-9 and CA72-4. Positive rate of CA72-4 was 58.3%, which was almost same as that of CEA. Lymph node metastasis and peritoneal dissemination were observed relatively high rate in positive cases with serum CA72-4. Comparison of an elevation time of CEA and CA72-4 in recurrent cases showed that CEA earlier than CA72-4 was 3 cases, CA72-4 earlier than CEA was 3 cases, and the others were about same. These results indicated that CA72-4 was a useful tumor marker as a follow up of recurrent gastric cancer.
Takahashi
Y
Y
Dept. of Surgery, Kanazawa University.
Mai
M
M
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood; D005500:Follow-Up Studies; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D008207:Lymphatic Metastasis; D010534:Peritoneal Neoplasms / Q000556:secondary; D013274:Stomach Neoplasms / Q000276:immunology* / Q000473:pathology
D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen